OTR-AC vs LGD-4033

OTR-AC wins for: Ultra-stable blood levels, lowest suppression risk in the SARM class, and best-in-class muscle preservation during a deficit or injury recovery. Ideal for recomp or conservative users prioritizing safety, joint relief, or healing.

LGD-4033 wins for: Outright anabolic power, sheer lean-mass gain per mg, and proven clinical backing for muscle-building in both clinical and recreational settings. The go-to for bulking, hard cuts, or when chasing maximum physique change—especially when suppression is managed proactively.

Pick OTR-AC if:

• Joint or tendon support is a primary research goal and minimizing suppression is essential.
• Recomp, muscle preservation in a calorie deficit, or maintenance after injury are main objectives.
• Once-daily dosing and highly stable serum levels are preferred for protocol simplicity.
• Literature-backed muscle sparing (ostarine) is prioritized over pure mass gains.
• Protocols include stacking with MK-677 or cardarine for a balanced recomp effect without major risk.

Pick LGD-4033 if:

• Maximizing lean-mass gain per cycle is the primary endpoint, even with greater suppression risk.
• Protocols involve bulking, aggressive cuts with enhanced strength retention, or bridging between AAS runs.
• A stronger anabolic ceiling or larger physique shift is required—e.g., for hard gainers or advanced users.
• Community experience and dosing ranges are already well-documented and easy to replicate.
• Shorter half-life allows flexible dosing windows and rapid intervention in case of side effects.